S233-1783 Screening compound: N-{[1-(2-methoxyethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}quinoline-6-carboxamide

S233-1783 Screening compound: N-{[1-(2-methoxyethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}quinoline-6-carboxamide
S233-1783 Screening compound: N-{[1-(2-methoxyethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}quinoline-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S233-1783
N-{[1-(2-methoxyethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}quinoline-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S233-1783

Molecular Formula

C22H27N3O3 (C22 H27 N3 O3)

Compound Name

N-{[1-(2-methoxyethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}quinoline-6-carboxamide

IUPAC name

N-{[(4aS7aR)-1-(2-methoxyethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}quinoline-6-carboxamide

SMILES

COCCN([C@H](CCC1)[C@]1(CNC(c1cc2cccnc2cc1)=O)CC1)C1=O

InChI

InChI=1S/C22H27N3O3/c1-28-13-12-25-19-5-2-9-22(19,10-8-20(25)26)15-24-21(27)17-6-7-18-16(14-17)4-3-11-23-18/h3-4,6-7,11,14,19H,2,5,8-10,12-13,15H2,1H3,(H,24,27)/t19-,22+/m1/s1

InChI Key

QKXIYMIFSXWJHK-KNQAVFIVSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

381.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.925

Distribution Coefficient, logD

1.925

Water Solubility, LogSw

-2.51

Polar Surface Area

58.299

Acid Dissociation Constant (pKa)

13.12

Base Dissociation Constant (pKb)

2.31

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

50.00

S233-1783 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with S233-1783 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S233-1783?
Check Price and Availability of S233-1783, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S233-1783 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S233-1783
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S233-1783
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S233-1783 available by request